These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6125865)

  • 1. Correlation of plasma and CSF prolactin with CSF GABA during neuroleptic treatment.
    Bowers MB; Meltzer HY; Heninger GR
    Life Sci; 1982 Jul; 31(1):59-65. PubMed ID: 6125865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF GABA in psychotic disorders.
    Bowers MB; Gold BI; Roth RH
    Psychopharmacology (Berl); 1980; 70(3):279-82. PubMed ID: 6777800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homovanillic acid and prolactin in plasma and CSF of medicated epileptic patients.
    Kalfakis N; Markianos M
    Epilepsia; 1987; 28(2):138-41. PubMed ID: 3816709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High doses of haloperidol in schizophrenia. A clinical, biochemical, and pharmacokinetic study.
    Zarifian E; Scatton B; Bianchetti G; Cuche H; Loo H; Morselli PL
    Arch Gen Psychiatry; 1982 Feb; 39(2):212-5. PubMed ID: 7065833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in cerebrospinal fluid neurochemistry during pregnancy.
    Altemus M; Fong J; Yang R; Damast S; Luine V; Ferguson D
    Biol Psychiatry; 2004 Sep; 56(6):386-92. PubMed ID: 15364035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of haloperidol in high doses in schizophrenia. Clinical, biochemical and pharmacokinetic study].
    Scatton B; Zarifian E; Bianchetti G; Cuche H; Loo H; Morselli PL
    Encephale; 1982; 8(1):1-8. PubMed ID: 7094868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-aminobutyric acid (GABA) in the CSF of schizophrenic patients before and after neuroleptic treatment.
    Lichtshtein D; Dobkin J; Ebstein RP; Biederman J; Rimon R; Belmaker RH
    Br J Psychiatry; 1978 Feb; 132():145-8. PubMed ID: 623945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of acute and repeated administration of gamma aminobutyric acid (GABA) on growth hormone and prolactin secretion in man.
    Cavagnini F; Invitti C; Pinto M; Maraschini C; Di Landro A; Dubini A; Marelli A
    Acta Endocrinol (Copenh); 1980 Feb; 93(2):149-54. PubMed ID: 7376786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of gamma-aminobutyric acid in human cerebrospinal fluid: downward revision of previous control values.
    Löscher W; Schmidt D
    Ther Drug Monit; 1984; 6(2):227-31. PubMed ID: 6740742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF levels of gamma-aminobutyric acid in schizophrenia. Low values in recently ill patients.
    van Kammen DP; Sternberg DE; Hare TA; Waters RN; Bunney WE
    Arch Gen Psychiatry; 1982 Jan; 39(1):91-7. PubMed ID: 7055411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders.
    Kasa K; Otsuki S; Yamamoto M; Sato M; Kuroda H; Ogawa N
    Biol Psychiatry; 1982 Aug; 17(8):877-83. PubMed ID: 7115838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia.
    Davila R; Gonzalez MA; Zumarraga M; Andia I; Guimon J; Silva RR; Friedhoff AJ
    Biol Psychiatry; 1995 Aug; 38(4):267-9. PubMed ID: 8547450
    [No Abstract]   [Full Text] [Related]  

  • 13. CSF GABA is reduced in first-episode psychosis and associates to symptom severity.
    Orhan F; Fatouros-Bergman H; Goiny M; Malmqvist A; Piehl F; ; Cervenka S; Collste K; Victorsson P; Sellgren CM; Flyckt L; Erhardt S; Engberg G
    Mol Psychiatry; 2018 May; 23(5):1244-1250. PubMed ID: 28289277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between serum testosterone levels, body mass index (BMI) and insulin in male patients with schizophrenia treated with atypical antipsychotics--olanzapine or risperidone.
    Konarzewska B; Galińska-Skok B; Waszkiewicz N; Łazarczyk-Kirejczyk J; Malus A; Simonienko K; Szulc A
    Neuro Endocrinol Lett; 2014; 35(1):50-7. PubMed ID: 24625910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin and neuroleptic drugs.
    Green AI; Brown WA
    Neurol Clin; 1988 Feb; 6(1):213-23. PubMed ID: 2898095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High plasma prolactin levels after long-term neuroleptic treatment.
    Zelaschi NM; Delucchi GA; Rodriguez JL
    Biol Psychiatry; 1996 May; 39(10):900-1. PubMed ID: 8860193
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of propranolol treatment in shizophrenia on CSF amine metabolites and prolactin.
    Belmaker RH; Ebstein RP; Dasberg H; Levy A; Sedvall G; Van Praag HM
    Psychopharmacology (Berl); 1979 Jun; 63(3):293-6. PubMed ID: 113817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small animal model for evaluating neuroleptic potency.
    Rosenberg JM; Lau-Cam CA
    J Pharm Sci; 1980 Jan; 69(1):74-7. PubMed ID: 6101619
    [No Abstract]   [Full Text] [Related]  

  • 19. Gamma-aminobutyric acid (GABA) in cerebrospinal fluid.
    Kuroda H
    Acta Med Okayama; 1983 Jun; 37(3):167-77. PubMed ID: 6224397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of 6-pyruvoyl-tetrahydropterin synthase deficiency demonstrates a more significant correlation of L-Dopa dosage with serum prolactin levels than CSF homovanillic acid levels.
    Ogawa A; Kanazawa M; Takayanagi M; Kitani Y; Shintaku H; Kohno Y
    Brain Dev; 2008 Jan; 30(1):82-5. PubMed ID: 17590551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.